Sensei Biotherapeutics, Inc. IPO Advisory
Share this IPO Profile:Smart Search
Company |
Symbol |
Price Range |
Issue Price |
Open |
Shares |
Trade Date |
| Sensei Biotherapeutics, Inc. | SNSE - NASDAQ |
$16.00-$18.00 | $19.00 | $24.70 | 7 million | 2/4/2021 |
| Citigroup, Piper Sandler, Berenberg | ||||||
Co-Manager(s): Oppenheimer | ||||||
| Health Care | ||||||
Filing(s): Filed 2021-01-15 Terms Added 2021-02-01 | ||||||
Sensei Biotherapeutics, Inc. Quote & Chart - Click for current quote - SNSE
IPO Boutique aggregates information on public companies and private companies, such as "SNSE" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.
About Sensei Biotherapeutics, Inc. (adapted from Sensei Biotherapeutics, Inc. prospectus):
They are an immunotherapy company engaged in the discovery and development of next-generation therapies with an initial focus on treatments for cancer
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
They are an immunotherapy company engaged in the discovery and development of next-generation therapies with an initial focus on treatments for cancer
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
IPO Boutique aggregates information on public companies and private companies, such as "SNSE" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.